An interview with Mary Lynn McPherson, PharmD, MA, BCPS, CPE, about the pharmacist’s role in the management of a patient’s chronic pain.
Year: 2014
A Recap of PAINWeek 2014
An interview with Kevin L. Zacharoff, MD and licensed, board-certified anesthesiologist about the PAINWeek 2014 conference.
Recap of the June 25 PainEDU Webinar: Standardizing the Assessment of Patients with Chronic Pain
An interview with Kevin L. Zacharoff, MD about standardizing the assessment of patients with chronic pain; a PainEDU June webinar recap.
Preview of PAINWeek 2014 – The National Conference on Pain for Frontline Practitioners
An interview with Debra Weiner, managing partner of Aventine Co., about what to expect at the PAINWeek 2014 national pain conference.
The Importance of Responsible Medication Storage
An interview with Doug Hebert and Shelly Mowrey about the importance of responsible medication shortage and substance abuse prevention.
The First Line of Tamper Resistance of Prescription Pain Medications is. . . You
One of the four definitions that the Merriam-Webster dictionary offers for tampering is “to render something harmful or dangerous by altering its structure or composition.” There is nothing in the definition about intention, such as intent to break the law, intent “to get high,” or other aberrant drug-related behaviors; just the fact that something that changes structure… Read more »
REMS Education Program
An interview with Kevin L. Zacharoff, MD and licensed, board-certified anesthesiologist about ER/LA opioid REMS and REMS education.
The Beers Criteria
Census data shows that the average number of people in the United States turning 65 each day is approximately 10,000. More people will turn 65 every day for the next 20 years, making this one of the fastest growing segments of the U.S. population. It is reasonable to think that the number of people seeking medical attention for pain-related… Read more »
The Association Between Negative Affect and Prescription Opioid Misuse in Patients With Chronic Pain
An interview with Marc O. Martel, PhD about the association between negative affect and prescription opioid misuse in patients with chronic pain.
Effectively Communicating Medication Benefits and Risks – Are We Getting Better?
At a time of ever-ratcheting concern about the safety of our food and the appropriate, safe use of prescription drugs, the Food and Drug Administration (FDA) has moved forward in the past with a number of initiatives to better protect public health. Among them are efforts that are likely to impact how pharmaceutical companies help… Read more »
